Eloxx Pharmaceuticals, Inc. (ELOX)
OTCMKTS
· Delayed Price · Currency is USD
0.120
0.00 (0.00%)
At close: Apr 29, 2026
Eloxx Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -6 | -3.14 | -17.05 | -36.07 | -66.73 | Upgrade
|
| Depreciation & Amortization | - | 0.16 | 0.81 | 0.7 | 0.96 | Upgrade
|
| Other Amortization | 0.25 | 0.47 | 0.26 | 0.54 | 0.42 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0.04 | -0.29 | - | 0.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.04 | 22.67 | Upgrade
|
| Stock-Based Compensation | 0.24 | 0.54 | 1.97 | 3.02 | 9.17 | Upgrade
|
| Other Operating Activities | -1.33 | -0.35 | -0.88 | 0.05 | -0.54 | Upgrade
|
| Change in Accounts Receivable | 2.72 | -2.72 | - | - | - | Upgrade
|
| Change in Accounts Payable | -2.63 | -0.35 | 2.68 | 1.64 | -0.32 | Upgrade
|
| Change in Other Net Operating Assets | 0.44 | 0.72 | -1.84 | -1.76 | -0.72 | Upgrade
|
| Operating Cash Flow | -6.33 | -4.72 | -14.34 | -31.85 | -35 | Upgrade
|
| Capital Expenditures | - | - | - | -0.07 | -0.09 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0.04 | 0.31 | - | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | 2.15 | Upgrade
|
| Investing Cash Flow | 0 | 0.04 | 0.31 | -0.07 | 2.06 | Upgrade
|
| Short-Term Debt Issued | - | 0.38 | 0.43 | - | - | Upgrade
|
| Long-Term Debt Issued | 2.87 | 3.67 | - | - | 11.87 | Upgrade
|
| Total Debt Issued | 2.87 | 4.05 | 0.43 | - | 11.87 | Upgrade
|
| Short-Term Debt Repaid | -0.3 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -1.26 | -0.61 | -9.4 | - | -11.38 | Upgrade
|
| Total Debt Repaid | -1.56 | -0.61 | -9.4 | - | -11.38 | Upgrade
|
| Net Debt Issued (Repaid) | 1.31 | 3.44 | -8.97 | - | 0.49 | Upgrade
|
| Issuance of Common Stock | - | - | 4.89 | - | 47.74 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -0.36 | Upgrade
|
| Other Financing Activities | 9.69 | - | - | 8.81 | 2.92 | Upgrade
|
| Financing Cash Flow | 11 | 3.44 | -4.08 | 8.81 | 50.79 | Upgrade
|
| Net Cash Flow | 4.68 | -1.24 | -18.11 | -23.1 | 17.84 | Upgrade
|
| Free Cash Flow | -6.33 | -4.72 | -14.34 | -31.91 | -35.09 | Upgrade
|
| Free Cash Flow Margin | - | -74.15% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.51 | -1.25 | -5.58 | -14.73 | -20.06 | Upgrade
|
| Cash Interest Paid | 0.03 | 0.14 | 0.99 | 1.37 | 0.73 | Upgrade
|
| Levered Free Cash Flow | -4.9 | -3.47 | -6.47 | -17.96 | -14.61 | Upgrade
|
| Unlevered Free Cash Flow | -4.49 | -3.22 | -6.01 | -17.28 | -14.25 | Upgrade
|
| Change in Working Capital | 0.52 | -2.36 | 0.84 | -0.12 | -1.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.